Search research articles
Contact Us
Filters
Showing results (231-240 of 264) with videos related to
Page
of 27
Sort By:
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Haematologica
|
December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma
Maria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
The Lancet. Digital Health
|
December 22, 2023
Deep learning for [<sup>18</sup>F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis
Ida Häggström, Doris Leithner, Jennifer Alvén, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic
Anna S Berghoff, Margaretha Gansterer, Arne C Bathke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study
Maximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Medicine
|
December 31, 2015
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
Ana-Iris Schiefer, Christoph Kornauth, Ingrid Simonitsch-Klupp, et al.
JAMA Oncology
|
September 30, 2021
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Maximilian J Mair, Julia M Berger, Anna S Berghoff, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Page
of 27
Search research articles
Search
Showing results (231-240 of 264) with videos related to
Sort By:
Page
of 27
Journal of Affective Disorders
|
August 5, 2023
Affective temperament, fatigue, and pain in cancer patients
Matthias Knefel, Elisabeth L Zeilinger, Andreas Erfurth, et al.
Haematologica
|
December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphoma
Maria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
The Lancet. Digital Health
|
December 22, 2023
Deep learning for [<sup>18</sup>F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysis
Ida Häggström, Doris Leithner, Jennifer Alvén, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 16, 2020
SARS-CoV-2 Testing in Patients With Cancer Treated at a Tertiary Care Hospital During the COVID-19 Pandemic
Anna S Berghoff, Margaretha Gansterer, Arne C Bathke, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 6, 2022
Third dose of SARS-CoV-2 vaccination in hemato-oncological patients and health care workers: immune responses and adverse events - a retrospective cohort study
Maximilian J Mair, Julia M Berger, Manfred Mitterer, et al.
Journal of Psychosomatic Research
|
December 17, 2024
The myth of a cancer-specific temperament: An analysis of affective temperament in cancer patients
Elisabeth L Zeilinger, Matthias Knefel, Andreas Erfurth, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 5, 2023
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma
Johannes Duell, Andreas K Buck, Philipp E Hartrampf, et al.
Medicine
|
December 31, 2015
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
Ana-Iris Schiefer, Christoph Kornauth, Ingrid Simonitsch-Klupp, et al.
JAMA Oncology
|
September 30, 2021
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations
Maximilian J Mair, Julia M Berger, Anna S Berghoff, et al.
Nuklearmedizin. Nuclear Medicine
|
January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges
Rudolf Werner, Alexander Haug, Christian Buske, et al.
Page
of 27